113 related articles for article (PubMed ID: 20581247)
1. Systemic microRNAs: novel biomarkers for colorectal and other cancers?
Heneghan HM; Miller N; Kerin MJ
Gut; 2010 Jul; 59(7):1002-4; author reply 1004. PubMed ID: 20581247
[No Abstract] [Full Text] [Related]
2. Exosomal microRNAs step into the biomarker arena.
Shih KK; Levine DA
Gynecol Oncol; 2008 Jul; 110(1):1-2. PubMed ID: 18589207
[No Abstract] [Full Text] [Related]
3. Plasma microRNAs: a potential biomarker for colorectal cancer?
Schetter AJ; Harris CC
Gut; 2009 Oct; 58(10):1318-9. PubMed ID: 19749133
[No Abstract] [Full Text] [Related]
4. [Serum markers for breast and colorectal cancers. Working group reunited by the National Health Agency for Accreditation and Evaluation (NHAAE)].
Mlika-Cabanne N; Bellet D
Gastroenterol Clin Biol; 1998 Apr; 22(4):442-57. PubMed ID: 9762275
[No Abstract] [Full Text] [Related]
5. Diagnostic and prognostic significance of serum microRNAs in colorectal cancer.
Menéndez P; Villarejo P; Padilla D; Menéndez JM; Montes JA
J Surg Oncol; 2013 Feb; 107(2):217-20. PubMed ID: 22903548
[TBL] [Abstract][Full Text] [Related]
6. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform.
Resnick KE; Alder H; Hagan JP; Richardson DL; Croce CM; Cohn DE
Gynecol Oncol; 2009 Jan; 112(1):55-9. PubMed ID: 18954897
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs are novel biomarkers of colorectal cancer.
Aslam MI; Taylor K; Pringle JH; Jameson JS
Br J Surg; 2009 Jul; 96(7):702-10. PubMed ID: 19526617
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs in colorectal cancer: function, dysregulation and potential as novel biomarkers.
Nugent M; Miller N; Kerin MJ
Eur J Surg Oncol; 2011 Aug; 37(8):649-54. PubMed ID: 21632200
[TBL] [Abstract][Full Text] [Related]
9. Biomarker update for breast, colorectal and non-small cell lung cancer.
Ross JS
Drug News Perspect; 2010; 23(1):82-8. PubMed ID: 20155222
[TBL] [Abstract][Full Text] [Related]
10. RNA is more sensitive than DNA in identification of breast cancer patients bearing tumor nucleic acids in plasma.
Silva J; Silva JM; García V; García JM; Domínguez G; Bonilla F
Genes Chromosomes Cancer; 2002 Dec; 35(4):375-6. PubMed ID: 12378534
[No Abstract] [Full Text] [Related]
11. A truth serum for cancer--microRNAs have major potential as cancer biomarkers.
Chin LJ; Slack FJ
Cell Res; 2008 Oct; 18(10):983-4. PubMed ID: 18833286
[No Abstract] [Full Text] [Related]
12. Circulating Non-coding RNA as Biomarkers in Colorectal Cancer.
Ferracin M; Lupini L; Mangolini A; Negrini M
Adv Exp Med Biol; 2016; 937():171-81. PubMed ID: 27573900
[TBL] [Abstract][Full Text] [Related]
13. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer.
Heneghan HM; Miller N; Lowery AJ; Sweeney KJ; Newell J; Kerin MJ
Ann Surg; 2010 Mar; 251(3):499-505. PubMed ID: 20134314
[TBL] [Abstract][Full Text] [Related]
14. [Circulating MicroRNAs as Biomarkers of Colorectal Cancer].
Umemura T; Kuroki C
Rinsho Byori; 2015 Mar; 63(3):336-46. PubMed ID: 26524857
[TBL] [Abstract][Full Text] [Related]
15. [Advantage of using tumor markers in colorectal and breast cancers. Guidelines of the American Society of Clinical Oncology (ASCO)].
Trillet-Lenoir V; Freyer G
Bull Cancer; 1997 Jul; 84(7):767-8. PubMed ID: 9339206
[No Abstract] [Full Text] [Related]
16. Found in transcription: gene expression and other novel blood biomarkers for the early detection of breast cancer.
Lönneborg A; Aarøe J; Dumeaux V; Børresen-Dale AL
Expert Rev Anticancer Ther; 2009 Aug; 9(8):1115-23. PubMed ID: 19671031
[TBL] [Abstract][Full Text] [Related]
17. Serum autoantibodies recognizing 5-hydroxymethyl-2'-deoxyuridine, an oxidized DNA base, as biomarkers of cancer risk in women.
Frenkel K; Karkoszka J; Glassman T; Dubin N; Toniolo P; Taioli E; Mooney LA; Kato I
Cancer Epidemiol Biomarkers Prev; 1998 Jan; 7(1):49-57. PubMed ID: 9456243
[TBL] [Abstract][Full Text] [Related]
18. N(1),N(12)-Diacetylspermine as a sensitive and specific novel marker for early- and late-stage colorectal and breast cancers.
Hiramatsu K; Takahashi K; Yamaguchi T; Matsumoto H; Miyamoto H; Tanaka S; Tanaka C; Tamamori Y; Imajo M; Kawaguchi M; Toi M; Mori T; Kawakita M
Clin Cancer Res; 2005 Apr; 11(8):2986-90. PubMed ID: 15837752
[TBL] [Abstract][Full Text] [Related]
19. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse.
Yie SM; Lou B; Ye SR; Cao M; He X; Li P; Hu K; Rao L; Wu SM; Xiao HB; Gao E
Ann Surg Oncol; 2008 Nov; 15(11):3073-82. PubMed ID: 18670822
[TBL] [Abstract][Full Text] [Related]
20. Does the presence of circulating tumor cells in the venous drainage of curative colorectal cancer resections determine prognosis? A meta-analysis.
Katsuno H; Zacharakis E; Aziz O; Rao C; Deeba S; Paraskeva P; Ziprin P; Athanasiou T; Darzi A
Ann Surg Oncol; 2008 Nov; 15(11):3083-91. PubMed ID: 18787906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
